Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 24 Apr 2023
Adding mint flavor to e-cigarette liquids increases the amount of vapour particles produced and is linked, according to a recent study published in Respiratory Research.
Read Full NewsMistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, limiting its role in routine oncology care.
A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.
1.
African American men see biggest survival gain from healthier lifestyles post prostate cancer diagnosis
2.
ctDNA Predicts Relapse in Locally Advanced Cervical Cancer
3.
The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.
4.
NIH research cuts leave cancer patient facing hard choice
5.
The Risk of Major Mortality is Associated with the Start of Opioids in Dementia.
1.
Unveiling the Invisible: The Transformative Role of Radiomics in Precision Oncology
2.
The Algorithmic Revolution: How AI is Reshaping Precision Oncology from Bench to Bedside
3.
The importance of understanding normal serum osmolality
4.
Understanding Leiomyoma: Causes, Symptoms, and Treatment Options
5.
Machine Learning in Genomic Analysis for Early Lung Cancer Detection: Key Advances and Insights
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
4.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge